Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,481.2
65.0 (2.69%)

 

  • STI Straits Times Index
    2,481.2
    65.0 (2.69%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,350.9
    22.0 (1.66%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    23,603.5
    428.4 (1.85%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,750.3
    3.1 (0.11%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    18,917.0
    -168.0 (-0.88%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    4,538.9
    124.4 (2.82%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,088.4M
  • Value: 1,896.9M
  • Rise: 240
  • Fall: 87
  • Unch: 484

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Genting Sing0.690+0.050
Singtel2.540+0.120
CapitaMall Trust1.790+0.040
ESR-REIT0.300-
Rex Intl0.088+0.002
IPS Securex0.054+0.004
CapitaCom Trust1.530+0.040
Medtecs Intl0.087+0.002
YZJ Shipbldg SGD0.830-
Ascendas Reit2.830+0.120

World Indices

World Indices
Name Last Change
Nasdaq 7,774.2 +271.8
HSI 23,603.5 +428.4
HSCEI 9,594.8 +192.6
Jakarta 4,538.9 +124.4
Nikkei 225 18,917.0 -168.0
SSE Comp 2,750.3 +3.1
Shanghai A 2,882.2 +3.2
Shanghai B 216.0 +0.9
KOSPI 1,754.6 +37.5

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

SELECTA BIOSCIENCES INC SELECTA BIOSCIENCES
Updated on 30 Mar 2020 (End of trading day)
Last (USD): 2.370 Change: +0.250 High: 2.590 Remarks: -
Change (%): +11.79 Low: 2.080
Open 2.110 Yesterday's Close 2.12
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 933,547 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.75603 Trailing EPS (USD) e -0.64048 NAV (USD) b 0.0972
PE a - Trailing PE f - Price / NAV b 24.3827
Dividend (USD) d - Cash In Hand (USD) g 1.0434 Issued & Paid-up Shares c 86,420,000
Dividend Yield (%) d - Price / Cash In Hand g 2.271 Treasury Shares h -
Beta - 75 Daysi 1.588 R-Squared - 75 Days(%)i 24.37 Market Cap (M) 204.815
Beta - 500 Daysi 0.835 R-Squared - 500 Days (%)i 4.20 Enterprise Value (M) 133.920
Piotroski F Score 2 Exchange Code SELB Par Value ( $ ) n.a.
52 Weeks Volatility (%) 99.58 Free Float (%) 65.1
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 16 Mar 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 20 Jun 2016.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference SELECTA BIOSCIENCES INC NASDAQ 204.815 - - 24.3827 -
Industry Biotechnology NASDAQ 2,290.659 261.495 240.653 5.4726 0.798
Local Peer AMGEN INC NASDAQ 122,962.963 14.649 15.680 12.7120 2.703
Local Peer GILEAD SCIENCES INC NASDAQ 95,596.629 17.525 17.749 4.2440 3.058
Local Peer VERTEX PHARMACEUTICAL NASDAQ 60,129.666 28.682 51.095 9.8812 -
Local Peer BIOGEN INC NASDAQ 55,026.852 12.419 9.345 4.1240 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 52,039.446 21.289 24.596 4.6926 -
Local Peer ILLUMINA INC NASDAQ 40,605.810 49.160 40.525 8.8025 -
Local Peer SEATTLE GENETICS INC NASDAQ 19,859.855 - - 10.5846 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 19,380.446 249.750 8.061 1.7140 -
Local Peer INCYTE CORPORATION NASDAQ 15,644.724 142.883 35.007 6.0209 -
Local Peer BIOMARIN PHARMACEUTICAL NASDAQ 14,842.096 - - 4.7455 -
Local Peer BIONTECH SE SPON ADS EACH REP 1 ORD SHS NASDAQ 14,060.360 - - 32.1110 -
Local Peer GALAPAGOS NV SPON ADR REPR 1 ORD SHS NASDAQ 12,340.241 - 39.761 4.4647 -
Other Local Peers ALNYLAM PHARMACEUTICALS INC (NASDAQ), MODERNA INC (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), EXACT SCIENCES CORP (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), 10X GENOMICS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), EXELIXIS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), FIBROGEN INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), ALKERMES PLC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), VIELA BIO INC (NASDAQ), ALECTOR INC (NASDAQ), UNIQURE N.V. (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), XENCOR INC (NASDAQ), EPIZYME INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), ARVINAS INC (NASDAQ), INSMED INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), CORTEXYME INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), REGENXBIO INC (NASDAQ), VERACYTE INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), NEXTCURE INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), NOVAVAX INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), PASSAGE BIO INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), OMEROS CORP (NASDAQ), RETROPHIN INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), AVROBIO INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), COMPUGEN (NASDAQ), BELLUS HEALTH INC (NASDAQ), PRECIGEN INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), ARDELYX INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), KURA ONCOLOGY INC (NASDAQ), ATHERSYS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), VERASTEM INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), AGENUS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), UROGEN PHARMA LTD (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), MERUS B V (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), NANTKWEST INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), XBIOTECH INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), MACROGENICS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), PERSONALIS INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), KAMADA (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), GERON CORP (NASDAQ), MANNKIND CORPORATION (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), ADURO BIOTECH INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), XOMA CORP (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), CABALETTA BIO INC (NASDAQ), IVERIC BIO INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), MEDICINOVA INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), CHIASMA INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), AFFIMED N V (NASDAQ), VAXART INC (NASDAQ), SAVARA INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), CELYAD ADS EACH REPR 1 ORD (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), INFLARX N V (NASDAQ), CHIMERIX INC (NASDAQ), IMV INC (NASDAQ), CONTRAFECT CORP (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), ARAVIVE INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), VERMILLION INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), AXCELLA HEALTH INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), VACCINEX INC (NASDAQ), OTONOMY INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), SESEN BIO INC (NASDAQ), ORGENESIS INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), SYNLOGIC INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), TREVENA INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), COHBAR INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), EQUILLIUM INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), RESTORBIO INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), SOLIGENIX INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), INMUNE BIO INC (NASDAQ), ADVAXIS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), ZAFGEN INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), EVOGENE LTD (NASDAQ), TOCAGEN INC (NASDAQ), ATYR PHARMA INC (NASDAQ), CURIS INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), BIOCARDIA INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), OCUGEN INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), CYCLACEL PHARMA IN (NASDAQ), BENITEC BIOPHARMA LTD SPON ADS EA REPR 200 ORD SHS(POST SPLIT) (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), PRECIPIO INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), SENESTECH INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ)
Global Peer CSL ASX 134,707.257 50.209 46.502 15.5760 0.894
Global Peer AMGEN-T HKEx 589,807.000 8.965 9.598 7.8255 4.417
Global Peer AGILENT TECHNOLOGIES INC NYSE 22,502.338 71.210 29.453 4.6416 0.842
Global Peer WUXI BIO HKEx 129,227.957 173.016 112.581 9.0366 -
Global Peer SINO BIOPHARM HKEx 128,569.389 11.999 49.895 - 0.716
Global Peer BEIGENE HKEx 76,697.393 - - 10.2299 -
Global Peer Lonza SGX 5,937.453 6.613 6.613 0.6568 4.787
Global Peer GENSCRIPT BIO HKEx 23,101.940 138.938 - 7.7454 -
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 2,834.000 45.199 51.905 2.6036 -
Global Peer 3SBIO HKEx 20,497.558 13.550 55.193 - -
Other Global Peers ALPHAMAB-B (HKEx), HAOHAI BIOTEC (HKEx), FRONTAGE (HKEx), VIVA BIOTECH (HKEx), KADMON HLDGS INC (NYSE), MYOVANT SCIENCES LTD (NYSE), POLYNOVO LIMITED (ASX), AVITA MEDICAL LTD (ASX), ARCUS BIOSCIENCES INC (NYSE), ASCENTAGE-B (HKEx), MESOBLAST LTD (ASX), ASCLETIS-B (HKEx), SINOMAB BIO-B (HKEx), NANOVIRICIDES INC (NYSE American), ESSEX BIO-TECH (HKEx), LEE'S PHARM (HKEx), BBI LIFE SCI (HKEx), DPHARMA (Bursa), PFENEX INC (NYSE American), TELIX PHARMACEUTIC (ASX), NEXT SCIENCE LTD (ASX), UNI-BIO GROUP (HKEx), LINEAGE CELL THERAPEUTICS INC (NYSE American), ENZO BIOCHEM INC (NYSE), CEL-SCI CORP (NYSE American), IBIO INC (NYSE American), 22ND CENTURY GROUP INC (NYSE American), PALATIN TECHNOLOGIES INC (NYSE American), AIM IMMUNOTECH INC (NYSE American), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), NEUREN PHARMACEUTICALS LTD (ASX), IMUGENE LIMITED (ASX), CT ENTERPRISE (HKEx), CYNATA THERAPEUTICS LTD (ASX), SYNTHETIC BIOLOGICS INC (NYSE American), ARMATA PHARMACEUTICALS INC (NYSE American), BIOTRON (ASX), BIOSINO BIO-TEC (HKEx), ORAGENICS INC (NYSE American), IMMUTEP LTD (ASX), INVEX THERAPEUTICS LTD NPV (ASX), HOLISTA COLLTECH LIMITED (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), KAZIA THERAPEUTICS LIMITED (ASX), MEMPHASYS LTD (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), ANTEOTECH LIMITED (ASX), REGENT PACIFIC (HKEx), ACTINOGEN MEDICAL LTD (ASX), Suntar Eco-City^ (SGX), REGENEUS LTD (ASX), GENETIC TECHNOLOGIES (ASX), CCP TECHNOLOGIES LTD (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), BIONOMICS LTD (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), HAO WEN HLDGS (HKEx), CONTANGO ASSET MANAGEMENT LIMITED (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), PATRYS LIMITED (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), RHINOMED LIMITED (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), ADALTA LTD (ASX), SIENNA CANCER DIAGNOSTICS LTD (ASX), BENITEC BIOPHARMA LTD (ASX), ANATARA LIFESCIENCES LTD (ASX), LEAF RESOURCES LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), AMPLIA THERAPEUTICS LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), CRYOSITE (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), NANOLLOSE LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.420
+21.54 %
10 Days -+0.380
+19.10 %
20 Days --1.330
-35.95 %
Medium Term Return 3 Months --0.010
-0.42 %
6 Months -+0.630
+36.21 %
1 Year --0.160
-6.32 %
Long Term Return 2 Years --7.540
-76.08 %
3 Years --11.670
-83.12 %
Annualised Return Annualised --
-44.73 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 1.280 - 4.830 Change From 1 Year Low +1.090 % Change From 1 Year Low (%) +85.16
Change From 1 Year High -2.460 % Change From 1 Year High (%) -50.93
2 Years Range 1.280 - 16.545 Change From 2 Years Low +1.090 % Change From 2 Years Low (%) +85.16
Change From 2 Years High -14.175 % Change From 2 Years High (%) -85.68
5 Years Range 1.280 - 28.000 Change From 5 Years Low +1.090 % Change From 5 Years Low (%) +85.16
Change From 5 Years High -25.630 % Change From 5 Years High (%) -91.54
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Selecta Biosciences, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. It produces the Synthetic Vaccine Particles (SVP) platform for immune tolerance and immune stimulation. The firm's proprietary pipeline includes SVP-enabled enzyme, oncology and gene therapies. The company was founded by Omid C. Farokhzad, Robert S. Langer Jr., and Ulrich von Andrian in 2007 and is headquartered in Watertown, MA.

Historical Price Data

Date Open High Low Close Volume VWAP
30 Mar 2020 2.110 2.590 2.080 2.370 933,547 -
27 Mar 2020 2.140 2.200 1.980 2.120 863,847 -
26 Mar 2020 2.190 2.203 2.060 2.140 413,375 -
25 Mar 2020 2.000 2.170 1.850 2.140 653,505 -
24 Mar 2020 2.030 2.180 1.830 1.950 1,155,438 -
23 Mar 2020 1.780 2.020 1.670 1.950 514,032 -
20 Mar 2020 1.760 2.139 1.720 1.730 1,723,579 -
19 Mar 2020 1.510 1.730 1.420 1.690 1,332,167 -
18 Mar 2020 1.920 2.080 1.440 1.500 867,647 -
17 Mar 2020 2.030 2.090 1.930 1.990 1,371,049 -
16 Mar 2020 2.190 2.200 1.900 1.960 1,327,278 -
13 Mar 2020 2.170 2.720 2.140 2.710 1,580,616 -
12 Mar 2020 2.750 2.850 1.960 2.080 2,600,096 -
11 Mar 2020 3.150 3.440 3.030 3.090 683,051 -
10 Mar 2020 3.560 3.680 2.940 3.190 735,932 -
09 Mar 2020 3.690 3.800 3.280 3.500 549,433 -
06 Mar 2020 3.890 4.013 3.850 3.860 460,429 -
05 Mar 2020 4.000 4.071 3.860 3.940 476,198 -
04 Mar 2020 4.050 4.115 3.870 3.900 807,836 -
03 Mar 2020 3.920 3.990 3.460 3.700 677,451 -
02 Mar 2020 4.030 4.040 3.840 3.890 443,334 -
28 Feb 2020 4.000 4.120 3.820 4.000 716,807 -
Summary
Current 2 Weeks
(17 Mar 2020 to 30 Mar 2020)
2.030 2.590 1.420 2.370 9,828,186 -
Previous 2 Weeks
(03 Mar 2020 to 16 Mar 2020)
3.920 3.990 1.420 1.960 9,898,320 -
4 Weeks from
(03 Feb 2020 to 02 Mar 2020)
3.550 3.920 1.420 3.890 15,427,196 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.